EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neurologic features in hospitalized patients with COVID-19: a prospective cohort in a catalan hospital

Oriol Barrachina-Esteve, A Anguita, A Reverter, J Espinosa, C Lafuente, M Rubio-Roy, M Crosas, C Vila-Sala, C Acero, M Navarro, D Cánovas, G Ribera und 2 weitere

Neurological Sciences · 2025

DOI: 10.1007/s10072-025-08031-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurological Sciences, 2025. Verfasst von Oriol Barrachina-Esteve und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Parc Taulí University Hospital, Parc Taulí Research and Innovation Institute Foundation (I3PT), Universitat Autònoma de Barc…. Hauptthemen laut MEDLINE: COVID-19, Nervous System Diseases, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat Autònoma de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To study the prevalence and timing of neurological manifestations, including cognitive involvement, in patients hospitalized for Coronavirus disease 2019 (COVID-19). To analyze the pathogenic mechanisms and any association they have with disease severity.

Methods

Longitudinal cohort study with prospective follow-up of patients who required hospitalization. Patients under 65 who had no pre-existing cognitive impairment and did not require an ICU stay were evaluated 3 and 12 months after discharge using a battery of neuropsychological tests.

Results

Of 205 patients hospitalized for COVID-19, 153 (74.6%) presented with neurological manifestations. The most frequent were myalgia (32.7%), headache (31.7%), dysgeusia (29.2%), and anosmia (24.9%). Patients with more severe illness at the time of hospitalization presented fewer neurological manifestations. Of the 62 patients who underwent neuropsychological examination 3 months after discharge, 22.6% had impaired attention, 19.4% impaired working memory, 16.1% impaired learning and retrieval, 9.7% impaired executive functions, and 8.2% impaired processing speed. Patients with anosmia also presented with more headache (OR 5.45; p < 0.001) and greater risk of working memory impairment (OR 5.87; p 0.03). At follow-up 12 months after hospital discharge, 14.3% of patients still showed impaired attention, 2.4% impaired working memory, 2.5% impaired executive functions, and 2.5% impaired processing speed.

Discussion

Neurological manifestations are common in patients hospitalized for COVID-19 regardless of severity. The high prevalence of anosmia and its association with headache and working memory impairment at 3 months, suggest potential direct or indirect damage to the prefrontal cortex via invasion of the olfactory bulb by COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Nervous System DiseasesCognitive DysfunctionHumansMaleFemaleMiddle AgedProspective StudiesHospitalizationSpainAdultAnosmiaLongitudinal StudiesNeuropsychological TestsAgedHeadache

Stichwörter der Autor:innen

COVID-19Clinical neurologyCognitive disordersNeurovirology

Autor:innen und Institutionen

  • Department of Neurology, Parc Taulí University Hospital, Parc Taulí Research and Innovation Institute Foundation (I3PT), Universitat Autònoma de Barcelona, Sabadell, Spain. Oriol.Barrachina@autonoma.cat.
  • Department of Neurology, Manacor Hospital, Manacor, Mallorca, Spain. Oriol.Barrachina@autonoma.cat.
  • Department of Neurology, Parc Taulí University Hospital, Parc Taulí Research and Innovation Institute Foundation (I3PT), Universitat Autònoma de Barcelona, Sabadell, Spain.
  • Department of Neurology, Sant Joan de Déu Hospital, Althaia Foundation, Manresa, Spain.
  • Department of Ophthalmology, Parc Taulí University Hospital, Parc Taulí Research and Innovation Institute Foundation (I3PT), Universitat Autònoma de Barcelona, Sabadell, Spain.
  • Department of Infectious Diseases, Parc Taulí University Hospital, Parc Taulí Research and Innovation Institute Foundation (I3PT), Universitat Autònoma de Barcelona, Sabadell, Spain.

Förderung

  • Universitat Autònoma de Barcelona

Zitieren

APA

Barrachina-Esteve, O., Anguita, A., Reverter, A., Espinosa, J., Lafuente, C., Rubio-Roy, M., Crosas, M., Vila-Sala, C., Acero, C., Navarro, M., Cánovas, D., Ribera, G., Jodar, M., & Estela, J. (2025). Neurologic features in hospitalized patients with COVID-19: a prospective cohort in a catalan hospital. Neurological Sciences. https://doi.org/10.1007/s10072-025-08031-y

Vancouver

Barrachina-Esteve O, Anguita A, Reverter A, Espinosa J, Lafuente C, Rubio-Roy M, et al. Neurologic features in hospitalized patients with COVID-19: a prospective cohort in a catalan hospital. Neurological Sciences. 2025. doi:10.1007/s10072-025-08031-y

BibTeX
@article{BarrachinaEsteve2025,
  author = {Barrachina-Esteve, Oriol and Anguita, A and Reverter, A and Espinosa, J and Lafuente, C and Rubio-Roy, M and Crosas, M and Vila-Sala, C and Acero, C and Navarro, M and Cánovas, D and Ribera, G and Jodar, M and Estela, J},
  title = {Neurologic features in hospitalized patients with COVID-19: a prospective cohort in a catalan hospital},
  journal = {Neurological Sciences},
  year = {2025},
  doi = {10.1007/s10072-025-08031-y}
}
Kostenlos starten →